Filter By Industry
Filter By Tag


Huateng Pharma Press releases

1 - 10 of 35 Press Releases

Mar 21, 2023
In recent years, targeted protein degradation (TPD) technology has developed rapidly, especially proteolysis targeting chimera (PROTAC), which is the most representative technology of TPD strategy.

Feb 20, 2023
Tetrahydrocurcumin (THC) has obvious antioxidant effect and has been used as a natural functional whitening raw material for cosmetics research and development.

Jan 28, 2023
Fluralaner is a systemic insecticide and acaricide that can be administered orally or topically. Bravecto is the trade name. The U.S.

Nov 28, 2022
Carfilzomib, a proteasome inhibitor, is indicated for the treatment of patients with multiple myeloma.

Oct 25, 2022
According to the latest IDF Diabetes map, the global prevalence of diabetes reached 10.5% in 2021, with 537 million adults living with diabetes. China has become a disaster zone for diabetes, with the largest number of adults with diabetes in the world.

Sep 26, 2022
Although the treatment of type 2 diabetes (T2DM) has made impressive progress in the past few decades, researchers are constantly searching for new treatments.

Aug 23, 2022
Since the COVID-19 epidemic, Pfizer and Moderna have used mRNA technology in a vaccine to help humans fight COVID-19.

Jul 26, 2022
Alzheimer's disease (AD) is a progressive, irreversible neurodegenerative disease clinically manifested by cognitive impairment, behavioral abnormalities, and social deficits.

Jun 28, 2022
A study conducted under the Lung Cancer Master Protocol (Lung-MAP) found that when treated with a combination of ramuzumab (Cyramza) and Keytruda,  Patients with advanced NSCLC whose cancer progressed during prior immunotherapy lived significantly...

May 26, 2022
Canagliflozin is a medication used to treat type 2 diabetes. Canagliflozin is a sodium-glucose cotransporter (SGLT2) inhibitor. Glucose filtered in the renal tubular lumen is mainly reabsorbed by SGLT2 expressed in the proximal renal tubule.

Page: 1 2 3 4 Next
Huateng Pharma RSS Feed